Pirozzi Claudio, Lama Adriano, Annunziata Chiara, Cavaliere Gina, Ruiz-Fernandez Clara, Monnolo Anna, Comella Federica, Gualillo Oreste, Stornaiuolo Mariano, Mollica Maria Pina, Raso Giuseppina Mattace, Ferrante Maria Carmela, Meli Rosaria
Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, 80131 Naples, Italy.
Department of Biology, University of Naples Federico II, Cupa Nuova Cinthia 21-Edificio 7, 80126 Naples, Italy.
Antioxidants (Basel). 2020 Nov 30;9(12):1201. doi: 10.3390/antiox9121201.
Lines of evidence have shown the embryogenic and transgenerational impact of bisphenol A (BPA), an endocrine-disrupting chemical, on immune-metabolic alterations, inflammation, and oxidative stress, while BPA toxic effects in adult obese mice are still overlooked. Here, we evaluate BPA's worsening effect on several hepatic maladaptive processes associated to high-fat diet (HFD)-induced obesity in mice. After 12 weeks HFD feeding, C57Bl/6J male mice were exposed daily to BPA (50 μg/kg per os) along with HFD for 3 weeks. Glucose tolerance and lipid metabolism were examined in serum and/or liver. Hepatic oxidative damage (reactive oxygen species, malondialdehyde, antioxidant enzymes), and mitochondrial respiratory capacity were evaluated. Moreover, liver damage progression and inflammatory/immune response were determined by histological and molecular analysis. BPA amplified HFD-induced alteration of key factors involved in glucose and lipid metabolism, liver triglycerides accumulation, and worsened mitochondrial dysfunction by increasing oxidative stress and reducing antioxidant defense. The exacerbation by BPA of hepatic immune-metabolic dysfunction induced by HFD was shown by increased toll-like receptor-4 and its downstream pathways (i.e., NF-kB and NLRP3 inflammasome) amplifying inflammatory cytokine transcription and promoting fibrosis progression. This study evidences that BPA exposure represents an additional risk factor for the progression of fatty liver diseases strictly related to the cross-talk between oxidative stress and immune-metabolic impairment due to obesity.
有证据表明,双酚A(BPA)这种内分泌干扰化学物质对免疫代谢改变、炎症和氧化应激具有胚胎发生和跨代影响,而BPA在成年肥胖小鼠中的毒性作用仍被忽视。在此,我们评估了BPA对小鼠中与高脂饮食(HFD)诱导的肥胖相关的几种肝脏适应性不良过程的恶化作用。在给予12周高脂饮食后,C57Bl/6J雄性小鼠每天与高脂饮食一起口服BPA(50μg/kg),持续3周。检测血清和/或肝脏中的葡萄糖耐量和脂质代谢。评估肝脏氧化损伤(活性氧、丙二醛、抗氧化酶)和线粒体呼吸能力。此外,通过组织学和分子分析确定肝脏损伤进展以及炎症/免疫反应。BPA加剧了高脂饮食诱导的参与葡萄糖和脂质代谢的关键因子的改变、肝脏甘油三酯积累,并通过增加氧化应激和降低抗氧化防御能力而使线粒体功能障碍恶化。高脂饮食诱导的肝脏免疫代谢功能障碍因BPA而加剧,表现为Toll样受体4及其下游途径(即核因子κB和NLRP3炎性小体)增加,从而放大炎症细胞因子转录并促进纤维化进展。本研究证明,BPA暴露是脂肪肝疾病进展的一个额外风险因素,这与肥胖引起的氧化应激和免疫代谢损伤之间的相互作用密切相关。